Turenne Capital
Investor profile
Venture capital
Also recorded as: Turenne Group
Deals
9
distinct rounds
Companies
9
backed
Active span
2017–2025
9 yrs
Total round €
€157M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Bpifrance3
- Kurma Partners2
- Omnes Capital2
- 3B Future Health Fund1
- adMare BioInnovations1
- Aurinvest1
- Charles River Laboratories1
- CTI Life Sciences1
- Eurazeo1
- FundPlus1
- Invus1
- M Capital Partners1
- Normandy1
- Novo Holdings1
- Panacea Venture1
- Schroders Capital1
- Seroba Life Sciences1
- Seventure Partners1
- Sham1
- SHS Capital1
- Theodorus1
- UI Investissement1
- Ventech1
- Verve Ventures1
- Vitruvian Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Singulart | France | 1 | €53M |
| Domain Therapeutics | France | 1 | €40M |
| Coave Therapeutics | France | 1 | €32M |
| PathoQuest | France | 1 | €15M |
| Infimed | France | 1 | €9.8M |
| StaffMe | France | 1 | €3.0M |
| Seraphin.legal | France | 1 | €2.0M |
| iBubble | France | 1 | €1.9M |
| Nachos Grill | France | 1 | €1.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Singulart | Series B | €53M | 2021-11 |
| Domain Therapeutics | Series A | €40M | 2022-05 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| PathoQuest | Series B | €15M | 2021-11 |
| Infimed | Other | €9.8M | 2018-01 |
| StaffMe | Series A | €3.0M | 2017-12 |
| Seraphin.legal | Other | €2.0M | 2020-04 |
| iBubble | Other | €1.9M | 2018-01 |
| Nachos Grill | Other | €1.0M | 2018-11 |